Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Sep. 30, 2015 $ 500 $ 57,755,900 $ (62,592,900) $ (4,836,500)
Balance at beginning (in shares) at Sep. 30, 2015 512,405      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   758,400   758,400
Extension Warrants issued to note holders   1,196,000   1,196,000
Note Warrants issued to note holders   1,365,200   1,365,200
Stock issued to vendor   6,900   6,900
Stock issued to vendor (in shares) 1,500      
Restricted stock compensation $ 100 69,300   69,400
Restricted stock compensation (in shares) 163,750      
Conversion of notes $ 1,300 6,315,700   6,317,000
Conversion of notes (in shares) 1,263,406      
Net loss     (5,940,900) (5,940,900)
Balance at end at Sep. 30, 2016 $ 1,900 67,467,400 (68,533,800) (1,064,500)
Balance at end (in shares) at Sep. 30, 2016 1,941,061      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   2,086,000   2,086,000
Stock issued to vendor   173,000   173,000
Stock issued to vendor (in shares) 26,250      
Restricted stock compensation $ 100 (100)  
Restricted stock compensation (in shares) 79,000      
Stock issued for private placement of shares $ 500 2,980,800   2,981,300
Stock issued for private placement of shares (in shares) 477,000      
Stock issued for purchase agreement to Aspire Capital   145,000   145,000
Stock issued for purchase agreement to Aspire Capital (in shares) 20,000      
Commitment shares issued to Aspire Capital pursuant to Purchase Agreement $ 100 (100)  
Commitment shares issued to Aspire Capital pursuant to Purchase Agreement (in shares) 80,000      
Common Stock issued to Arcadian   5,900   5,900
Common Stock issued to Arcadian (in shares) 1,000      
Common Stock - public offering $ 1,700 7,480,400   7,482,100
Common Stock - public offering (in shares) 1,675,000      
Offering costs - legal fees Aspire   (148,600)   (148,600)
Net loss     (7,112,800) (7,112,800)
Balance at end at Sep. 30, 2017 $ 4,300 $ 80,189,700 $ (75,646,600) $ 4,547,400
Balance at end (in shares) at Sep. 30, 2017 4,299,311